Table 2.
a)
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP | Chr | Gene | MA | Dataset | MAFA | MAFU | P-value | OR | Pooled P-value | Pooled OR | Fisher Meta P | I2/Q |
rs2180341 | 6q22.33 | ECHDC1; RNF146 | C | MSKCC | 0.28 | 0.19 | 6.86×10-4 | 1.64 | 4.77×10-3 | 1.28 | 6.40×10-3 | 56%/4.6 |
BCFR | 0.25 | 0.22 | 2.51×10-1 | 1.20 | ||||||||
NYUMC | 0.25 | 0.24 | 7.48×10-1 | 1.05 | ||||||||
| ||||||||||||
rs6569479 | 6q22.33 | ECHDC1; RNF146 | A | MSKCC | 0.27 | 0.19 | 5.81×10-3 | 1.50 | 1.06×10-2 | 1.25 | 2.94×10-2 | 15%/2.4 |
BCFR | 0.25 | 0.22 | 2.70×10-1 | 1.19 | ||||||||
NYUMC | 0.26 | 0.24 | 5.74×10-1 | 1.09 | ||||||||
| ||||||||||||
rs6569480 | 6q22.33 | ECHDC1; RNF146 | A | MSKCC | 0.27 | 0.19 | 1.77×10-3 | 1.58 | 5.62×10-3 | 1.27 | 1.19×10-2 | 39%/3.3 |
BCFR | 0.25 | 0.22 | 2.70×10-1 | 1.19 | ||||||||
NYUMC | 0.26 | 0.24 | 5.82×10-1 | 1.09 | ||||||||
| ||||||||||||
rs7776136 | 6q22.33 | ECHDC1; RNF146 | A | MSKCC | 0.27 | 0.19 | 2.58×10-3 | 1.56 | 7.85×10-3 | 1.26 | 1.68×10-2 | 38%/3.2 |
BCFR | 0.25 | 0.22 | 2.54×10-1 | 1.19 | ||||||||
NYUMC | 0.26 | 0.24 | 6.60×10-1 | 1.07 | ||||||||
| ||||||||||||
rs1078806 | 10q | FGFR2 | C | MSKCC | 0.44 | 0.39 | 7.66×10-2 | 1.25 | 1.70×10-6 | 1.43 | 9.64×10-6 | 25%/2.7 |
BCFR | 0.46 | 0.38 | 7.72×10-3 | 1.43 | ||||||||
NYUMC | 0.48 | 0.35 | 1.05×10-4 | 1.69 | ||||||||
| ||||||||||||
rs7203563 | 16p13.3 | A2BP1 | C | MSKCC | 0.12 | 0.08 | 2.26×10-2 | 1.60 | 4.10×10-2 | 1.30 | 5.50×10-3 | 75%/8.0 |
BCFR | 0.11 | 0.07 | 2.43×10-2 | 1.70 | ||||||||
NYUMC | 0.07 | 0.09 | 1.93×10-1 | 0.72 | ||||||||
| ||||||||||||
rs3012642 | Xq13.1 | PHKA1; HDAC8 | G | MSKCC | 0.06 | 0.03 | 2.44×10-2 | 2.01 | 8.91×10-3 | 1.64 | 3.84×10-2 | 18%/2.4 |
BCFR | 0.06 | 0.03 | 5.37×10-2 | 1.86 | ||||||||
NYUMC | 0.03 | 0.03 | 9.85×10-1 | 0.99 |
b)
| ||||||||||||
SNP | Chromosome | Gene | Minor Allele | Dataset | MAF (cases) | MAF (controls) | P-value | OR | Pooled P-value | Pooled OR | Meta P-value | |
| ||||||||||||
rs11200014 | 10q | FGFR2 | A | NYUMC | 0.48 | 0.35 | 1.23×10-4 | 1.68 | N/A | N/A | N/A | |
| ||||||||||||
rs2981579 | 10q | FGFR2 | A | NYUMC | 0.48 | 0.36 | 1.67×10-4 | 1.66 | N/A | N/A | N/A | |
| ||||||||||||
rs1078806 | 10q | FGFR2 | G | MSKCC | 0.44 | 0.39 | 7.66×10-2 | 1.25 | 1.70×10-6 | 1.43 | 9.64×10-6 | |
BCFR | 0.46 | 0.38 | 7.72×10-3 | 1.43 | ||||||||
NYUMC | 0.48 | 0.35 | 1.05×10-4 | 1.69 | ||||||||
| ||||||||||||
rs1219648 | 10q | FGFR2 | G | NYUMC | 0.48 | 0.36 | 2.67×10-4 | 1.63 | N/A | N/A | N/A | |
| ||||||||||||
rs2420946 | 10q | FGFR2 | T | NYUMC | 0.48 | 0.37 | 9.57×10-3 | 1.56 | N/A | N/A | N/A | |
| ||||||||||||
rs2981582 | 10q | FGFR2 | A | NYUMC | 0.48 | 0.37 | 9.57×10-3 | 1.56 | N/A | N/A | N/A |
MA=minor allele; MAF=minor allele frequency for Cases (“A”) and Controls (“U”); p-values based on χ2 test on allele counts between cases and controls. All 3 datasets were combined for pooled P-values and Ors and Fisher Meta-analysis. Cochran Q and I2 statistics for heterogeneity are reported (“I2/Q”).